| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.04. | Wipro Limited: Wipro ernennt Srini Pallia zum CEO und Geschäftsführer | 792 | Business Wire | Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), ein führendes Technologie- und Beratungsunternehmen, gab heute die Ernennung von Srini Pallia zum Chief Executive Officer und Geschäftsführer des... ► Artikel lesen | |
| 06.04. | Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society | 1.010 | Business Wire | KarXT demonstrated a favorable long-term metabolic profile where most patients experienced stability or improvements on metabolic parameters over 52 weeks of treatment A majority of patients (65%)... ► Artikel lesen | |
| 06.04. | Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society | 995 | Business Wire | Long-term treatment with KarXT was associated with continued improvements in symptoms of schizophrenia across all efficacy measures at 52 weeks More than 75% of participants achieved 30% improvement... ► Artikel lesen | |
| 06.04. | Teva Pharmaceutical Industries Limited: New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY (risperidone) Extended-Release Injectable Suspension at SIRS 2024 | 1.140 | Business Wire | PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable (LAI) formulation of risperidone microspheres (R064766)... ► Artikel lesen | |
| 06.04. | Daiichi Sankyo: ENHERTU Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors | 2.085 | Business Wire | Based on three phase 2 trials of Daiichi Sankyo and AstraZeneca's ENHERTU that showed clinically meaningful responses across a broad range of tumors
ENHERTU now has five approved indications... ► Artikel lesen | |
| 06.04. | SSR Mining Inc.: SSR Mining Provides Update on Çöpler Incident | 1.308 | Business Wire | SSR Mining Inc. (Nasdaq/TSX: SSRM; ASX: SSR) ("SSR Mining" or the "Company") provides an update on the ongoing recovery efforts at the Çöpler mine in Türkiye.
Since the February 13, 2024 incident... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 5.159 |
| EVOTEC | 2.305 |
| SUPER MICRO COMPUTER | 2.274 |
| BAYER | 2.152 |
| NEL | 2.145 |
| MICROSTRATEGY | 1.831 |
| RHEINMETALL | 1.160 |
| TUI | 917 |
| TESLA | 865 |
| PORSCHE AG | 773 |
| COINBASE GLOBAL | 763 |
| SNOWFLAKE | 734 |
| PALANTIR TECHNOLOGIES | 713 |
| VOLKSWAGEN | 625 |
| ALPHABET | 601 |
| AMAZON | 585 |
| THYSSENKRUPP | 583 |
| RENK GROUP | 579 |
| GAMESTOP | 530 |
| MERCEDES-BENZ | 525 |
| BIONTECH | 514 |
| AIXTRON SE | 509 |
| BITCOIN GROUP SE | 472 |
| BYD | 461 |
| BASF | 455 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
